These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 20584070

  • 1. Effects of telmisartan and enalapril on renoprotection in patients with mild to moderate chronic kidney disease.
    Nakamura T, Fujiwara N, Kawagoe Y, Sugaya T, Ueda Y, Koide H.
    Eur J Clin Invest; 2010 Sep; 40(9):790-6. PubMed ID: 20584070
    [Abstract] [Full Text] [Related]

  • 2. Renoprotective effect of telmisartan in patients with chronic kidney disease.
    Nakamura T, Inoue T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Node K.
    Clin Exp Hypertens; 2008 Oct; 30(7):662-72. PubMed ID: 18855269
    [Abstract] [Full Text] [Related]

  • 3. Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.
    Frimodt-Møller M, Høj Nielsen A, Strandgaard S, Kamper AL.
    Nephrol Dial Transplant; 2010 Mar; 25(3):842-7. PubMed ID: 19903661
    [Abstract] [Full Text] [Related]

  • 4. Reduction of proteinuria with angiotensin receptor blockers.
    Galle J.
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S36-43. PubMed ID: 18580865
    [Abstract] [Full Text] [Related]

  • 5. Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial.
    Barnett A.
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S132-5. PubMed ID: 16565237
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH, Bain SC, Bouter P, Karlberg B, Madsbad S, Jervell J, Mustonen J, Diabetics Exposed to Telmisartan and Enalapril Study Group.
    N Engl J Med; 2004 Nov 04; 351(19):1952-61. PubMed ID: 15516696
    [Abstract] [Full Text] [Related]

  • 7. Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study.
    Barnett AH.
    Acta Diabetol; 2005 Apr 04; 42 Suppl 1():S42-9. PubMed ID: 15868119
    [Abstract] [Full Text] [Related]

  • 8. Telmisartan in the treatment of hypertension in patients with chronic renal insufficiency.
    Weinbergová O, Metelka R, Vymetal J, Konecný K, Kosatíková Z.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul 04; 148(1):69-73. PubMed ID: 15523550
    [Abstract] [Full Text] [Related]

  • 9. Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
    Nakamura T, Inoue T, Suzuki T, Kawagoe Y, Ueda Y, Koide H, Node K.
    Hypertens Res; 2008 May 04; 31(5):841-50. PubMed ID: 18712038
    [Abstract] [Full Text] [Related]

  • 10. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
    Krairittichai U, Chaisuvannarat V.
    J Med Assoc Thai; 2009 May 04; 92(5):611-7. PubMed ID: 19459520
    [Abstract] [Full Text] [Related]

  • 11. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Barnett A.
    Am J Med; 2006 May 04; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
    [Abstract] [Full Text] [Related]

  • 12. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M, Tabuchi T, Minami Y, Takahashi Y, Itoh T, Nakamura M.
    Clin Ther; 2009 Oct 04; 31(10):2113-25. PubMed ID: 19922882
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
    Abe M, Okada K, Maruyama T, Matsumoto S, Matsumoto K.
    Int J Clin Pharmacol Ther; 2010 Mar 04; 48(3):206-13. PubMed ID: 20197015
    [Abstract] [Full Text] [Related]

  • 14. Telmisartan attenuates chronic ciclosporin A nephrotoxicity in a pig model.
    Cibulskyte D, Pedersen M, Hørlyck A, Marcussen N, Hansen HE, Frøkiaer J, Madsen M, Mortensen J.
    Nephrol Dial Transplant; 2007 Feb 04; 22(2):369-75. PubMed ID: 17107964
    [Abstract] [Full Text] [Related]

  • 15. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C, Falasca K, Mancino P, Di Iorio A, Vecchiet J.
    Eur Rev Med Pharmacol Sci; 2012 Apr 04; 16(4):491-8. PubMed ID: 22696876
    [Abstract] [Full Text] [Related]

  • 16. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X, Matavelli LC, Ono H, Frohlich ED.
    Am J Physiol Renal Physiol; 2005 Oct 04; 289(4):F871-9. PubMed ID: 15900021
    [Abstract] [Full Text] [Related]

  • 17. Renoprotective effects of telmisartan in patients with advanced chronic kidney disease.
    Tokunaga M, Kabashima N, Serino R, Shibata T, Matsumoto M, Miyamoto T, Miyazaki M, Furuno Y, Nakamata J, Fujimoto Y, Takeuchi M, Abe H, Okazaki M, Otsuji Y, Tamura M.
    Clin Nephrol; 2010 Feb 04; 73(2):139-46. PubMed ID: 20129021
    [Abstract] [Full Text] [Related]

  • 18. [In the DETAIL. Kidney protection in manifestations of microalbuminuria].
    MMW Fortschr Med; 2006 Jun 29; 148(26):51. PubMed ID: 16875382
    [No Abstract] [Full Text] [Related]

  • 19. Comparative study of enalapril vs. losartan on residual renal function preservation in automated peritoneal dialysis. A randomized controlled study.
    Reyes-Marín FA, Calzada C, Ballesteros A, Amato D.
    Rev Invest Clin; 2012 Jun 29; 64(4):315-21. PubMed ID: 23227581
    [Abstract] [Full Text] [Related]

  • 20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.